PCDH20: A Potential Drug Target and Biomarker (G64881)

Target Name: PCDH20

NCBI ID: G64881

PCDH20

PCDH20: A Potential Drug Target and Biomarker

PCDH20 is a protein that is expressed in many tissues of the body, including epithelial, mesenchymal, and neural cells. It is a member of the cadherin family, which is a transmembrane protein that plays a critical role in cell-cell adhesion. In this article, we will discuss PCDH20 as a drug target and its potential as a biomarker for various diseases.

PCDH20 as a Drug Target

PCDH20 has been identified as a potential drug target due to its unique structure and its involvement in several cellular processes. One of the key reasons for its potential as a drug target is its high expressivity, i.e., expression in a variety of tissues and organs The amount is higher. Additionally, PCDH20 has the ability to interact with other proteins, making it an attractive drug target.

The role of PCDH20 in tumor occurrence and development

The role of PCDH20 in tumorigenesis and progression has been extensively studied. Many studies have shown that the expression level of PCDH20 is closely related to tumor invasion and metastasis. In addition, the expression level of PCDH20 is also related to the timetable of tumor occurrence and development.

The role of PCDH20 in skin diseases

PCDH20 also plays an important role in skin diseases. For example, PCDH20 has been used as a drug target to treat cutaneous squamous cell carcinoma. Studies have shown that inhibition of PCDH20 can significantly inhibit the invasiveness and metastasis of cutaneous squamous cell carcinoma.

The role of PCDH20 in neurological diseases

PCDH20 also plays an important role in the nervous system. For example, PCDH20 has been used as a drug target to treat neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease. Research shows that inhibition of PCDH20 can significantly improve symptoms of neurodegenerative diseases.

The role of PCDH20 as a biomarker

PCDH20 can also be used as a biomarker to detect certain diseases. For example, some studies have shown that PCDH20 can serve as a biomarker for Parkinson's disease. In addition, PCDH20 can also serve as a biomarker for Alzheimer's disease.

Conclusion

In conclusion, PCDH20 is a protein that has been identified as a potential drug target due to its unique structure and its involvement in several cellular processes. PCDH20 has also been shown to be a potential biomarker for various diseases, including cancer and neurodegenerative diseases. Further research is needed to fully understand the role of PCDH20 as a drug target and biomarker.

Protein Name: Protocadherin 20

Functions: Potential calcium-dependent cell-adhesion protein

The "PCDH20 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PCDH20 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets